(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochloride → (S)-N-(quinuclidine-8-yl)-2-(piperidin-1-yl)benzoxazole-4-carboxamide

HRID 249830

反応式

HRID 249830 の反応式
[N:1]1([C:7]2[O:8][C:9]3[C:10](=[C:12]([C:16]([OH:18])=O)[CH:13]=[CH:14][CH:15]=3)[N:11]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.Cl.Cl.[NH2:21][C@H:22]1[CH:27]2[CH2:28][CH2:29][N:24]([CH2:25][CH2:26]2)[CH2:23]1>>[N:24]12[CH2:23][C@@H:22]([NH:21][C:16]([C:12]3[CH:13]=[CH:14][CH:15]=[C:9]4[O:8][C:7]([N:1]5[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]5)=[N:11][C:10]=34)=[O:18])[CH:27]([CH2:28][CH2:29]1)[CH2:26][CH2:25]2

参加物

3

反応物 2

HCID 12494973(3S)-1-azabicyclo[2.2.2]octan-3-amine dihydrochlorideHCID 668737802-(Piperidin-1-yl)benzoxazole-4-carboxylic acid

生成物 1

HCID 66873975(S)-N-(quinuclidine-8-yl)-2-(piperidin-1-yl)benzoxazole-4-carboxamide

実験手順

Following general procedure GP-C1, a mixture of 2-(piperidin-1-yl)benzoxazole-4-carboxylic acid and (S)-(−)-3-aminoquinuclidine dihydrochloride were coupled to provide (S)—N-(quinuclidine-8-yl)-2-(piperidin-1-yl)benzoxazole-4-carboxamide which was converted to the hydrochloride salt following general procedure GP-D1. 1H NMR and MS consistent.

出典と根拠

ORDレコード
ord-c453c317dff3429d83613009dea980ee
出典データセット
uspto-grants-2011_01
特許番号
US07863271B2

関連ノート

読み込み中…